Red Violet Inc美股招股说明书(2026-08-06版)

1,666,667 shares ofCommon Stock Red Violet, Inc. (“red violet,” the “Company,” “we,” “our,” or “us”) is offering 1,666,667 shares of our common stock, par value$0.001 (“Common Stock”), pursuant to this prospectus supplement and the accompanying prospectus. The public offering price for eachshare of Common Stock is $60.00. Our Common Stock is listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “RDVT.” On August 5, 2026, the lastreported sale price of our Common Stock on Nasdaq was $68.28. We are a “smaller reporting company” under applicable Securities and Exchange Commission (the “SEC”) rules and, as such,have elected to comply with certain reduced public company disclosure requirements for this prospectus supplement, accompanyingprospectus and future filings. See “Prospectus Supplement Summary - Implications of Being a Smaller Reporting Company.” Investing in our securities involves substantial risks. See "Risk Factors" beginning on page S-6 of this prospectussupplement and the risk factors described in the accompanying prospectus, in our Annual Report on Form 10-K for the fiscalyear ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, and in any otherdocument incorporated by reference herein, for factors you should consider before purchasing our securities. (1)See “Underwriting” for a full description of compensation payable to the underwriters in connection with this offering. The underwriters may also exercise their option to purchase up to an additional 250,000 shares of Common Stock, at the publicoffering price, less underwriting discounts and commissions, for 30 days after the date of this prospectus supplement. The underwriters expect to deliver the securities against payment on or about August 7, 2026. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved ofthese securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is acriminal offense. Joint Bookrunning Managers Co-Managers The date of this prospectus supplement is August 5, 2026. TABLE OF CONTENTS PROSPECTUS SUPPLEMENT ABOUT THIS PROSPECTUS SUPPLEMENTS-iiCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSS-iiiPROSPECTUS SUPPLEMENT SUMMARYS-1THE OFFERINGS-5RISK FACTORSS-6USE OF PROCEEDSS-7DIVIDEND POLICYS-8MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR HOLDERS OF COMMON STOCKS-9UNDERWRITINGS-14LEGAL MATTERSS-22EXPERTSS-22WHERE YOU CAN FIND ADDITIONAL INFORMATIONS-22INCORPORATION OF CERTAIN INFORMATION BY REFERENCES-23 PROSPECTUS ABOUT THIS PROSPECTUSiiCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSiiiPROSPECTUS SUMMARY1RISK FACTORS3USE OF PROCEEDS3DESCRIPTION OF CAPITAL STOCK3DESCRIPTION OF DEBT SECURITIES6DESCRIPTION OF DEPOSITARY SHARES15DESCRIPTION OF WARRANTS17DESCRIPTION OF UNITS18GLOBAL SECURITIES19PLAN OF DISTRIBUTION21DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES23LEGAL MATTERS23EXPERTS23WHERE YOU CAN FIND ADDITIONAL INFORMATION23INCORPORATION OF CERTAIN INFORMATION BY REFERENCE24 ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the SECutilizing a “shelf” registration process. This document is in two parts. The first part is this prospectus supplement, which describes thespecific terms of this offering and the securities offered hereby and also adds to and updates information contained in the accompanyingprospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The secondpart, the accompanying base prospectus, gives more general information and disclosure about the securities we may offer from time totime, some of which does not apply to this offering of securities. When we refer to the prospectus, we are referring to both partscombined, and when we refer to the accompanying prospectus, we are referring to the base prospectus. If the description of this offering varies between this prospectus supplement and the accompanying prospectus, you should relyon the information in this prospectus supplement. This prospectus supplement, the accompanying prospectus, any free writing prospectusand the documents incorporated into each by reference include important information about us and the securities being offered and otherinformation you should know before investing. You should read this prospectus supplement and the accompanying prospectus togetherwith the additional information described under the heading “Where You Can Find Additional Information” in this prospectus supplementand the accompanying prospectus before investing in our securities. Any statement made in this prospectus or in a document incorporated or deemed to be incorporated by reference into thisprospectus will be deemed to be modified or superseded for purposes of this prospectus to